---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-030618"
form_type: "8-K"
ticker: "SER"
cik: "0001708599"
company_name: "Serina Therapeutics, Inc."
filed_at: "2023-08-30T23:59:59+00:00"
generated_at: "2026-06-11T02:01:37.515123+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# AgeX Therapeutics to acquire Serina in reverse merger; Serina holders to own ~75%

## Summary
- AgeX stockholders expected to own ~25%, Serina holders ~75% on fully-diluted basis post-close.
- AgeX to issue 3 warrants per 5 shares held (exercise $13.20, expiring July 31, 2025) and Incentive Warrants ($18, 4-year term).
- Juvenescence (43.34% holder) commits $15M capital via warrant exercise; cancels out-of-the-money warrants.
- Post-close board of 7 directors; Steve Ledger interim CEO, Randall Moreadith CSO, Tacey Viegas COO.
- Closing conditions: reverse split to ~2.5M shares, stock price >=$12, AgeX cash >=$500k; termination fee $1M.

## SEC filing metadata
- accession: 0001493152-23-030618
- form_type: 8-K
- ticker: SER
- cik: 0001708599
- company_name: Serina Therapeutics, Inc.
- filed_at: 2023-08-30T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1708599/000149315223030618/0001493152-23-030618-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1708599/000149315223030618/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-030618
- JSON: https://secwatch.observer/filing/0001493152-23-030618.json
- Plain text: https://secwatch.observer/filing/0001493152-23-030618.txt

## Key facts
- Material Agreements
  Serina Therapeutics, Inc. entered into Agreement and Plan of Merger and Reorganization with AgeX Therapeutics, Inc. (effective 2023-08-29).
  - Action: entry
  - Agreement: merger
  - Counterparty: AgeX Therapeutics, Inc.
  - Effective: 2023-08-29
  source text: On August 29, 2023, AgeX Therapeutics, Inc. (“ AgeX ”) entered into an Agreement and Plan of Merger and Reorganization (the “ Merger Agreement ”) with Serina Therapeutics Inc., an Alabama corporation (“ Serina ”), and Canaria Transaction Corporation, an Alabama corporation and wholly owned subsidiary of AgeX (“ Merger Sub ”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1708599/000149315223030618/0001493152-23-030618-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.